Saudi Journal of Kidney Diseases and Transplantation

CASE REPORT
Year
: 2018  |  Volume : 29  |  Issue : 4  |  Page : 967--970

Nephromegaly in an infant with atypical hemolytic-uremic syndrome resolving successfully with eculizumab


Gurinder Kumar 
 Division of Pediatric Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

Correspondence Address:
Dr. Gurinder Kumar
Division of Pediatric Nephrology, Sheikh Khalifa Medical City, Abu Dhabi
United Arab Emirates

Atypical hemolytic-uremic syndrome (aHUS) can pose a diagnostic challenge due to the multisystem involvement and varied manifestations. Early diagnosis and initiation of Eculizumab have been reported to have favorable renal outcomes. We report a case of 11-month-old male infant who presented at the age of two months with anemia, acute kidney injury, hypertension, and nephromegaly. Renal biopsy confirmed the diagnosis of aHUS and Eculizumab was started. Thrombotic microangiopathy markers showed the resolution. Kidney sizes improved after nine months of Eculizumab therapy. The successful resolution of nephromegaly in an infant with aHUS has not been reported so far in literature. Renal sizes should be monitored in all children with aHUS.


How to cite this article:
Kumar G. Nephromegaly in an infant with atypical hemolytic-uremic syndrome resolving successfully with eculizumab.Saudi J Kidney Dis Transpl 2018;29:967-970


How to cite this URL:
Kumar G. Nephromegaly in an infant with atypical hemolytic-uremic syndrome resolving successfully with eculizumab. Saudi J Kidney Dis Transpl [serial online] 2018 [cited 2020 Jul 7 ];29:967-970
Available from: http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=967;epage=970;aulast=Kumar;type=0